“Quality of life, care giver burden, and prevalence of depression and anxiety in caregivers of children with neurogenic bladder” –
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2022 - 2023
Project Lead
Dr. Rajkiran Raju S,
Authors
Dr. Rajkiran Raju S, Dr. Nivedita Kamath, Dr. Avita Johnson, Mrs Sumithra Selvam, Anamika Sebastian (MBBS), Shristi Prasad (MBBS), Shruthy, Anna Jijo (MBBS).
Project Status
completed